3rd Annual Inhalation and Respiratory Drug Delivery Conference

About the Conference

We were happy to welcome our partners, speakers and all participants on our “3rd Annual Inhalation and Respiratory Drug Delivery Conference” which was on the 8th – 29th of September 2022 in Berlin Germany!

3rd Annual Inhalation and Respiratory Drug Delivery Conference provided unique platform and gather leading experts, senior executives and professionals from the industry with great opportunity to discuss the latest innovations and trends in inhalation and respiratory market, formulation & delivery of inhaled therapies, the new challenges and approaches of the inhaler models and technologies.
Presentations from well-known speakers covered a wide spectrum of topics, feature key case studies on the latest trends in inhalation devices, connected devises, combination products, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.

Meet some of our speakers

Wilbur de Kruijf

CTO / General Manager

Resyca

Dr. Nuria Roldan

Project Leader

AlveoliX

Dr. William J. Ganley

Head of Computational Pharmaceutics

Nanopharm

Dr. Carsten Ehrhardt

Professor in Pharmaceutics and Biopharmaceutics

Trinity College Dublin

Ulf Krueger

CEO and Founder

Pulmotree Medical GmbH

To get complete conference program with full list of speaking partners please request the brochure

Request brochure

Key Practical Points

Innovation in nebulized therapy
Evolution in Nebulizers for Pulmonary Delivery
Novel technologies for pulmonary & nasal delivery
Challenges of developing a generic inhaled product
Dry-powder inhalers (DPIs) and Metered-dose inhalers (MDIs)
New analytical insights into dry powder formulations for inhalation
Future directions in inhalation and respiratory drug delivery research
Current and upcoming challenges in inhalation and respiratory market
Discover collaborative solutions to inhalation devices & combination products
Discuss the latest advancements in digital & smart inhalers and transforming digital devices to combination devices

Who Should Attend

This conference will gather together: CEOs, CTOs, CIOs, COOs, SVPs, VPs, Directors, Global Heads, Heads, Managers, Team Leaders, Specialists, Strategists, Planners and Officers of the following divisions:

Medical Devices & Injectors
Particles Characterization
Product Development
Regulatory Affairs
Respiratory Medicines
Risk Management
E-health Inhalation
Generics & Respiratory
New Delivery Technologies
Scientific Research
Connective Health
Inhalation product developers
Formulation Development
Inhaled Dosage Systems
Respiratory regulation representatives
Respiratory therapists
Pulmonary Pharmacology & Therapeutics
Lungs & airway disorder specialists
Allergists/Immunologists
Lungs and airway disorder specialists
Control, support and testing specialists
Medical technology and service provides
Intubation and ventilation product suppliers
Head specialists in respiratory drug delivery products
Medical research fellows, professors and academic representatives
Allergy & Asthma research Organizations, Academies, Societies Asthma, COPD, allergy and – immunology specialists
Inhalation & respiratory drug device engineering technologists
Respiratory Drug Development & Manufacturing
Respiratory Pharmacology
Respiratory associates
Medical suppliers
Home healthcare providers
Drug quality and design specialists
Medical marketing representatives
Senior research fellows & professors
Scientific researchers
Inhalation therapists
Drug delivery specialists

“3rd Annual Inhalation and Respiratory Drug Delivery Conference”

8th – 9th September 2022 in Berlin Germany will take place at our Official Hotel Partner

NH Berlin Alexanderplatz